SEATTLE, July 19, 2021, (MEDGADGET) — Global Photopheresis Products Market Analysis
Blood is infused with photosensitizing chemicals and bombarded with precise wavelengths of light in photopheresis, a kind of apheresis and photodynamic treatment. Extracorporeal photopheresis or ECP is another name for it. ECP is a leukapheresis-based therapy method licensed by the US FDA for the treatment of advanced cutaneous T-cell lymphoma. ECP is also used to treat type I diabetes, GVHD (graft versus host disease), scleroderma, Crohn’s disease, lupus erythematosus, lichen planus, and atopic dermatitis, among other conditions. There are several photopheresis products on the market, including open and closed systems, but only the closed system has been authorized by the US FDA due to the decreased potential risk and infection during reinfusion. Additionally, compared to open systems, closed systems are technologically sophisticated.
Get Sample PDF Brochure with Impact of COVID19: https://www.coherentmarketinsights.com/insight/request-pdf/2653
The global photopheresis products market is forecast to develop as the incidence of autoimmune illnesses and the incidence of organ transplant occurrences rise. Governments’ increased compensation criteria is expected to increase the global photopheresis product market. Mallinckrodt Pharmaceuticals, a renowned specialty pharmaceutical business, announced in August 2016 that the Swiss FDHA (Federal Department of Home Affairs) had authorized ECP therapy payment for Swiss patients.
Moreover, commercial tactics such as cooperation amongst important actors in the photopheresis industry contribute to a better knowledge of photopheresis’ influence on immune modulation in a variety of acute and critical illnesses. Mallinckrodt plc. signed a research partnership agreement with Transimmune AG, a firm that develops innovative immunotherapies, in February 2019 for the development of antigen presentation cell activation. Both firms plan to investigate the Mallinckodt photopheresis technology of the future.
Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!
Exclusive offer!!! Purchase the report at a discounted rate!!!
Get Discount For Buyers UPTO 30% OFF On Any Research Report
Buy Now with Discount for Premium Report 2021: https://www.coherentmarketinsights.com/promo/buynow/2653
The scarcity of photopheresis treatment centers, as well as the high cost and product recalls associated with the procedure, is expected to limit growth of the global photopheresis products market. As per a 2017 report by the American Society of Hematology, the number of cGVHD (chronic graft versus host disease) patients in the U.S. grew from 16 in 2009 to 100 in 2016, with ECP usage increasing from 31.3 percent in 2009 to 54 percent in 2016. The overall yearly cost per patient was US$ 190,148, which included US$ 4619 in ER visits and US$ 176,856 in hospitalization over the follow-up period.
Furthermore, on April 5, 2016, the manufacturer Mallinckrodt recalled the photopheresis product THERAKOS CELLEX after the post-marketing validation discovered an increased trend in tubing leaks within the pump tubing organizer.
The government of North America maintains a dominating position in the global photopheresis products market since it reimburses for numerous therapies such as GVHD, cytotoxic T-lymphocytes, and lung transplantation treated with ECP therapy. These are the reasons driving the market’s growth. As per the Leukemia and Lymphoma Society, 30-70 percent of individuals had cGVHD in 2017. Furthermore, the market is projected to be driven by regular approvals by regulatory bodies including the European Commission for photophoresis products. Swiss regulators authorized coverage of Mallinckrodt plcECP’s therapy for patients with bronchiolitis obliterans syndrome (BOS) after a lung transplant in August 2016.
We value your investment and offer customization as per your requirements.
Share your precise requirements @ https://www.coherentmarketinsights.com/insight/request-customization/2653
Major companies contributing in the global photopheresis products market are Terumo Corporation, Fresenuis Kabi AG, Macopharma, Mallinckrodt Pharmaceuticals, Med Tech Solutions GmbH, Haemonetics Corporation, and Dover Medical.
Table of Content
Global Photopheresis Products Market Research Report
Section 1: Global Photopheresis Products Industry Overview
Section 2: Global Economic Impact on Photopheresis Products Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: Photopheresis Products Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy, and Downstream Buyers
Section 10: Strategies and key policies by Distributors/Suppliers/Traders
Section 11: Key Marketing Strategy Analysis, by Market Vendors
Section 12: Market Effect Factors Analysis
Section 13: Global Photopheresis Products Market Forecast
Other Exclusive Reports:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027